Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial Biotech Investing
Naturally Splendid Extends Filing Deadline for Annual Financial Statements and MD&A Cannabis Investing News
Algernon Presents “The Science of Ifenprodil” on a Special BioPub Webcast Hosted by Dr. KSS, MD, PhD Pharmaceutical Investing
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program Pharmaceutical Investing
Graph Blockchain Announces Non-Binding Letter of Intent to Procure PPE Products Pharmaceutical Investing
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
